Ruben Abagyan

23PUBLICATIONS
45CO-AUTHORS
Molecular targetsPharmacogenomicsTheoretical quantum chemistryMajor global burdens of diseaseComputational chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 27, 2026
Temporal Dynamics of PD-L1 Surface in RKO Cells: Characterizing the Reversible Impact of the Small-Molecule Dimerizer BMS-202.

|May 13, 2024
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.

Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan

|Apr 26, 2024
Efficient Generation of Conformer Ensembles Using Internal Coordinates and a Generative Directional Graph Convolution Neural Network.

Eugene Raush, Ruben Abagyan, Maxim Totrov

|Feb 26, 2024
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events.

Tigran Makunts, Siranuysh Grabska, Hovakim Grabski

|Dec 04, 2023
Thyroid hyperplasia and neoplasm adverse events associated with GLP-1 receptor agonists in FDA Adverse Event Reporting System.

Tigran Makunts, Haroutyun Joulfayan, Ruben Abagyan

|May 09, 2023
High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds.

Conall Sauvey, Ittipat Meewan, Gretchen Ehrenkaufer

Pageof 4

Frequent Collaborators

5 joint publications

Tigran Makunts

5 joint publications

Da Shi

2 joint publications

Conall Sauvey

2 joint publications

Weiguang Seetoh